These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34713343)

  • 21. Keeping up to date: a current review of wearable cardioverter defibrillator use.
    Ashraf S; Ilyas S; Siddiqui F; Ando T; Shokr M; Panaich S; Briasoulis A; Afonso L; Khan M
    Acta Cardiol; 2020 Dec; 75(8):695-704. PubMed ID: 31687917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wearable cardioverter-defibrillators: A review of evidence and indications.
    Cheung CC; Olgin JE; Lee BK
    Trends Cardiovasc Med; 2021 Apr; 31(3):196-201. PubMed ID: 32205034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Wearable defibrillator : Current evidence].
    Duncker D; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):362-368. PubMed ID: 30357452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The wearable cardioverter defibrillator - temporary protection against sudden cardiac death].
    Almqvist M; Mattsson G; Magnusson P
    Lakartidningen; 2019 Apr; 116():. PubMed ID: 31192401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China.
    Jiang X; Ming WK; You JHS
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2387-2396. PubMed ID: 31502350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    Gassanov N; Mutallimov M; Caglayan E; Erdmann E; Er F
    J Cardiol; 2022 Dec; 80(6):573-577. PubMed ID: 35985868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collaborative care for the wearable cardioverter defibrillator patient: Getting the patient and medical team "vested and active".
    Sears SF; Tripp C; Huber NL; Khan S; Nekkanti R; Burch AE; Pokorney SD
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2509-2515. PubMed ID: 32757437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
    Israel C; Staudacher I; Leclercq C; Botto GL; Scherr D; Fach A; Duru F; Zylla MM; Katus HA; Thomas D
    Clin Res Cardiol; 2022 Nov; 111(11):1189-1197. PubMed ID: 35305126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparameter Monitoring with a Wearable Cardioverter Defibrillator.
    Rohrer U; Manninger M; Zirlik A; Scherr D
    Sensors (Basel); 2021 Dec; 22(1):. PubMed ID: 35009564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death.
    Kutyifa V; Vermilye K; Daimee UA; McNitt S; Klein H; Moss AJ
    Europace; 2018 Sep; 20(FI2):f225-f232. PubMed ID: 29905788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW; Vamos M; Sirat AS; Hohnloser SH
    Clin Res Cardiol; 2017 Apr; 106(4):300-306. PubMed ID: 27888304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.
    Kuehn C; Ruemke S; Rellecke P; Lichtenberg A; Joskowiak D; Hagl C; Hassan M; Leyh RG; Erler S; Garbade J; Eifert S; Grieshaber P; Boening A; Doenst T; Velichkov I; Madej T; Knaut M; Hain A; Burger H
    Eur J Cardiothorac Surg; 2022 May; 61(5):1031-1040. PubMed ID: 35174386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections.
    Castro L; Pecha S; Linder M; Vogler J; Gosau N; Meyer C; Willems S; Reichenspurner H; Hakmi S
    J Cardiothorac Surg; 2017 Nov; 12(1):99. PubMed ID: 29178898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the wearable cardioverter-defibrillator - the Swiss experience.
    Kovacs B; Reek S; Sticherling C; Schaer B; Linka A; Ammann P; Brenner R; Krasniqi N; Müller AS; Dzemali O; Kobza R; Grebmer C; Haegeli L; Berg J; Mayer K; Schläpfer J; Domenichini G; Reichlin T; Roten L; Burri H; Eriksson U; Saguner AM; Steffel J; Duru F; Swiss Wcd Registry
    Swiss Med Wkly; 2020 Sep; 150():w20343. PubMed ID: 33035354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).
    Klein HU; Meltendorf U; Reek S; Smid J; Kuss S; Cygankiewicz I; Jons C; Szymkiewicz S; Buhtz F; Wollbrueck A; Zareba W; Moss AJ
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):353-67. PubMed ID: 19889186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    Sasaki S; Shoji Y; Ishida Y; Kinjo T; Tsushima Y; Seno M; Nishizaki F; Itoh T; Izumiyama K; Yokota T; Yokoyama H; Yamada M; Horiuchi D; Kimura M; Higuma T; Tomita H; Okumura K
    J Cardiol; 2017 Jan; 69(1):359-363. PubMed ID: 27595899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.